Title: ACUTE LYMPHOBLASTIC LEUKEMIA STUDY GROUP OF INDIA ALL SGI Dr
1ACUTE LYMPHOBLASTIC LEUKEMIASTUDY GROUP OF
INDIAALL SGI
- Dr Suresh Advani
- Mumbai , INDIA.
2ALLMAGNITUDE OF PROBLEM IN INDIA
- Population 1 Billion
- Pop. lt 18 yrs 40
- New cases/ yr 8000
- Per capita GNP US 350
- National Priority ID Nutritional
Diseases -
- 1 in 7 people in the world, Indian!
3ALL IN INDIA FACTS
- 8000 new cases/yrlt 1000 adequately Rxed
- Mostly Morphological diagnosis
- No National data available
- Tough gt 70 cured in West, in India except in
major centres results still very poor. - Cost of Rx 1500 affordability 70/2 5/5
- Access to Rx PCUs infrastructure
- Most are HR late presentation biology?
- Females under represented
4ALL IN INDIA - BACKGROUND
- Before 90s Survival rate of lt 30
- Rx not organized
- Criteria for protocol entry not well defined
- Diff. protocols used even in same Institution!
- 1st effort to organize ALL Rx was by
- Dr Ian Magrath The NCI initiative 1985
- ACI TMH AIIMS
5OAS 65.5
n688
6All IN INDIA NCI INITIATIVE
- Helped to
- organize Rx for ALL
- develop infrastructure
- Rx patients uniformly- inside/outside
- anticipate problems deal with them
- identify some prognostic factors
- The success with MCP 841 protocol at the National
level has been the impetus to form the ALLSGI !
7ALLSGI FORMATION
- Jan 27, 2001 Pre ISMPO Hyderabad
-
- Why now?
- More trained Oncs Many trained with us
- PCUs increasing
- SIOP Initiative Training of Peds
- INCTR Initiative expertise, training, res.
- Better Communication Transport
8ALL SGI INITIAL OBJECTIVES
- To get organized
- To get used to data collection
- Identifying participating centers
- Try to develop infrastructure at participating
centers (Dx Nursing BBMicrobiology) - Chalk out short term objectives long term goals!
9ALL SGI FORMATION OF ZONES
- India is Big Country Many centers, Many Pts
- North Zone AIIMS, Delhi
- East Zone KMC, Calcutta
- South Zone ACI,Chennai
- West Zone TMH, Mumbai
- Central data collection Monitoring unit
10(No Transcript)
11ALL SGIWhat Have We Achieved So Far
- -Data of gt2000 patients treated uniformly on a
single protocol - Publications from individual centres
- Publications of data as a group
12Event-Free Survival by Center
TMH
Percent Event Free Survival
AIIMS
CI
Years since start of therapy
13Risk Factors (EFS) Multivariate Analysis
- WBC at AIIMS and Mumbai (p0.0005 and 0.002
respectively), not at CI - But best risk group still lt 70 EFS
- No significant risk factors could be identified
at Chennai nor in Pre B or Pre-T separately - No very high or very low risk groups identifiable
at all three centers - Early response not studied
Extensive analysis performed by experienced NCI
statisticians
14Temporal Changes with Identical Protocol
1995-96
1989-90
Percent Event Free Survival
1991-92, 93-94
1986-87
TMH 2 yr intervals 101-163 patients per group
Years since start of therapy
A 1986-87 B 1988-90 C 1991-92 D 1993-94
E 1995-96 F 1997
15Translocations in ALL
Childhood , USA
16ALL SGI TO WRITE GRANTS
- Grant from Lady Ratan Tata Trust For Developing
the Cooperative Group - To Write Grants For
- Epidemological studies Clinical Molecular
- Clinical studies
- Lab studies Pathogenesis, Mol. Biology
- Preventive Aspects
17ALL SGI ALL TREATMENT
- Develop infrastructure
- Rx data initially only from limited centers
- To continue established protocol (e.g. MCP 841)
at these centers - Investigational protocol(e.g. MCP 943) only at
zonal centers - Highest quality of information must be assured
Diag, data collection, data analysis - Once group established, only then to think about
ALL National Protocol- keeping in mind simplicity
cost!
18ALL SGI LONG TERM GOALS RESEARCH INITIATIVES
- Is ALL in India Biologically different?
- Std risk factors do not show diff in outcome
- many remission deaths
- Delays in Rx hepatitis, toxicity,etc
- Socioeconomic risk profile
- Toxicity profile
- Nutritional status
- Pharmacokinetics, Pharmacogenomics
- Difference in Leukemic cell or Patient ??
19ALL FUTURE PLANS